Early Hydrogen-Oxygen Gas Mixture Inhalation in Patients With Aneurysmal Subarachnoid Hemorrhage (HOMA)
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 206 participants.
Also called NCT05282836
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 206 participants
- Sponsor
- Registry
-
NCT05282836
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT05282836. Randomized; single masking; primary purpose treatment. Start 2022-03-15 (anticipated); primary completion 2023-03-15 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Early Hydrogen-Oxygen Gas Mixture Inhalation in Patients With Aneurysmal Subarachnoid Hemorrhage (HOMA)
- Acronym
- HOMA
- Condition
- Aneurysmal Subarachnoid Hemorrhage
- Intervention (Device)
- Hydrogen Oxygen Generator with Nebulizer
- Lead sponsor
- Beijing Tiantan Hospital
Record details
- Record id
cardio:ct-nct05282836- Content hash
50496a222cc3f2a2df014c0bff412d154f1e1b7654b082a04213b4ef12255a62